BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35065293)

  • 1. Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine.
    Shi C; Pei M; Wang Y; Chen Q; Cao P; Zhang L; Guo J; Deng W; Wang L; Li X; Gong Z
    Biochem Biophys Res Commun; 2022 Feb; 594():1-7. PubMed ID: 35065293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.
    Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL
    J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3.
    Lang DH; Yeung CK; Peter RM; Ibarra C; Gasser R; Itagaki K; Philpot RM; Rettie AE
    Biochem Pharmacol; 1998 Oct; 56(8):1005-12. PubMed ID: 9776311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular reactivity stimulated by TMA and TMAO: Are perivascular adipose tissue and endothelium involved?
    Restini CBA; Fink GD; Watts SW
    Pharmacol Res; 2021 Jan; 163():105273. PubMed ID: 33197599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3.
    Iglesias-Carres L; Chadwick-Corbin SA; Sweet MG; Neilson AP
    J Nutr Biochem; 2023 Oct; 120():109428. PubMed ID: 37549832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?
    Coutinho-Wolino KS; de F Cardozo LFM; de Oliveira Leal V; Mafra D; Stockler-Pinto MB
    Eur J Nutr; 2021 Oct; 60(7):3567-3584. PubMed ID: 33533968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneously hypertensive rats exhibit increased liver flavin monooxygenase expression and elevated plasma TMAO levels compared to normotensive and Ang II-dependent hypertensive rats.
    Gawryś-Kopczyńska M; Szudzik M; Samborowska E; Konop M; Chabowski D; Onyszkiewicz M; Ufnal M
    Front Physiol; 2024; 15():1340166. PubMed ID: 38681141
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of three oral pathogens on the TMA-TMAO metabolic pathway.
    Wang X; Chen L; Teng Y; Xie W; Huang L; Wu J; Wang H; Xie S
    Front Cell Infect Microbiol; 2024; 14():1413787. PubMed ID: 38836053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible correlation between high circulatory levels of trimethylamine-N-oxide and 2177G>C polymorphisms of hepatic flavin containing monooxygenase 3 in Kurdish Population with non-alcoholic fatty liver disease.
    Moradzad M; Abdi M; Sheikh Esmaeili F; Ghaderi D; Rahmani K; Moloudi MR; Vahabzadeh Z
    Mol Biol Rep; 2022 Jul; 49(7):5927-5937. PubMed ID: 35348964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?
    He M; Tan CP; Xu YJ; Liu Y
    Food Res Int; 2020 Dec; 138(Pt B):109812. PubMed ID: 33288187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.
    Fennema D; Phillips IR; Shephard EA
    Drug Metab Dispos; 2016 Nov; 44(11):1839-1850. PubMed ID: 27190056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats.
    Zhao ZH; Xin FZ; Zhou D; Xue YQ; Liu XL; Yang RX; Pan Q; Fan JG
    World J Gastroenterol; 2019 May; 25(20):2450-2462. PubMed ID: 31171889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD.
    Li X; Hong J; Wang Y; Pei M; Wang L; Gong Z
    Front Mol Biosci; 2021; 8():733507. PubMed ID: 34660695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro.
    Nian F; Zhu C; Jin N; Xia Q; Wu L; Lu X
    Biochem Biophys Res Commun; 2023 Aug; 669():134-142. PubMed ID: 37271025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
    Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
    Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation.
    Bennett BJ; de Aguiar Vallim TQ; Wang Z; Shih DM; Meng Y; Gregory J; Allayee H; Lee R; Graham M; Crooke R; Edwards PA; Hazen SL; Lusis AJ
    Cell Metab; 2013 Jan; 17(1):49-60. PubMed ID: 23312283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous Measurement of Urinary Trimethylamine (TMA) and Trimethylamine
    Jia X; Osborn LJ; Wang Z
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders.
    Praveenraj SS; Sonali S; Anand N; Tousif HA; Vichitra C; Kalyan M; Kanna PV; Chandana KA; Shasthara P; Mahalakshmi AM; Yang J; Pandi-Perumal SR; Sakharkar MK; Chidambaram SB
    Mol Neurobiol; 2022 Nov; 59(11):6684-6700. PubMed ID: 35986843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats.
    Maksymiuk KM; Szudzik M; Gawryś-Kopczyńska M; Onyszkiewicz M; Samborowska E; Mogilnicka I; Ufnal M
    J Transl Med; 2022 Oct; 20(1):470. PubMed ID: 36243862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethylamine But Not Trimethylamine Oxide Increases With Age in Rat Plasma and Affects Smooth Muscle Cells Viability.
    Jaworska K; Konop M; Hutsch T; Perlejewski K; Radkowski M; Grochowska M; Bielak-Zmijewska A; Mosieniak G; Sikora E; Ufnal M
    J Gerontol A Biol Sci Med Sci; 2020 Jun; 75(7):1276-1283. PubMed ID: 31411319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.